Mechanism of Action and Epitopes of Clostridium difficile Toxin B-neutralizing Antibody Bezlotoxumab Revealed by X-ray CrystallographyPeter Orth, Alex G. Therien, Grigori Ermakov et al.|Journal of Biological Chemistry|2014Cited by 138
Functional defects in Clostridium difficile TcdB toxin uptake identify CSPG4 receptor-binding determinantsPulkit Gupta, Roman A. Melnyk, Zhifen Zhang et al.|Journal of Biological Chemistry|2017Cited by 57
Broad Coverage of Genetically Diverse Strains of Clostridium difficile by Actoxumab and Bezlotoxumab Predicted by <i>In Vitro</i> Neutralization and Epitope ModelingLorraine D. Hernandez, Alex G. Therien, Fred Racine et al.|Antimicrobial Agents and Chemotherapy|2014Cited by 54
Clostridium difficile toxin B CROP domain in complex with FAB domains of neutralizing antibody bezlotoxumabPeter Orth, Alex G. Therien, Le Xiao et al.|Unknown|2013Cited by 0